Pancreatic Cancer Research

ResearcherUniversità Campus Bio-MedicoActive in the last 2 years

Vincenzo La Vaccara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9355-5771; OpenAlex author ID A5071083564. Sources: OpenAlex.

Their work

Papers
15 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2021: 2 papers · 2022: 2 papers · 2023: 4 papers · 2024: 1 paper · 2025: 2 papers · 2026: 4 papers

Papers 15

  1. Multicenter IGoMIPS Registry-based analysis of robotic versus laparoscopic approach to left pancreatectomy for pancreatic cancer. Co-author DOI 10.1007/s13304-026-02831-3↗
  2. Plasma Protein Corona Fingerprinting Across Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcinoma: A Comparative Proof-of-Concept Study. First author DOI 10.3390/cancers18203275↗
  3. Exploratory PET/CT Radiomics for Predicting Early Progression in Locally Advanced Pancreatic Cancer. Co-author DOI 10.3390/diagnostics16101499↗
  4. Pancreatic Steatosis as a Risk Phenotype for Pancreatic Ductal Adenocarcinoma: A Narrative Review. First author DOI 10.3390/medicina62040729↗
  5. Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. Co-author DOI 10.1039/d4nr02435d↗
  6. Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma: Aligning Guideline Recommendations with Real-World Evidence. Co-author DOI 10.3390/cancers17183085↗
  7. The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies. Co-author DOI 10.1097/js9.0000000000000755↗
  8. Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection. Co-author DOI 10.1097/js9.0000000000000558↗
  9. Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers15072013↗
  10. Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going. Co-author DOI 10.3390/jcm12113677↗
  11. Role of preoperative sarcopenia in predicting postoperative complications and survival after pancreatoduodenectomy for pancreatic cancer. Co-author PMID 36810297↗
  12. Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives. First author DOI 10.3390/biomedicines10092091↗
  13. Role of Neoplastic Markers in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/jcm11216509↗
  14. CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis. First author DOI 10.3389/fonc.2021.690580↗
  15. Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles. Co-author DOI 10.3390/cancers13205155↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Damiano D. Caputo · 13 shared papers, 2021–2026 · strength 2.83
  2. Roberto Coppola · 11 shared papers, 2021–2026 · strength 2.32
  3. Roberto Cammarata · 8 shared papers, 2022–2026 · strength 1.92
  4. Alessandro Coppola · 9 shared papers, 2021–2024 · strength 1.53
  5. Sara Ramella · 4 shared papers, 2021–2026 · strength 0.75
  6. Michele Fiore · 4 shared papers, 2021–2026 · strength 0.75
  7. Sara Elsa Aita · 2 shared papers, 2026 · strength 0.62
  8. Erica Quagliarini · 3 shared papers, 2021–2025 · strength 0.55
  9. Giulio Caracciolo · 3 shared papers, 2021–2025 · strength 0.55
  10. Daniela Pozzi · 3 shared papers, 2021–2025 · strength 0.55
  11. Luca Digiacomo · 2 shared papers, 2021–2025 · strength 0.36
  12. Heinz Wilfried Amenitsch · 2 shared papers, 2021–2025 · strength 0.36
  13. Francesco Giovinazzo · 1 shared paper, 2023 · strength 0.18
  14. Rolando Maria D’Angelillo · 1 shared paper, 2024 · strength 0.18
  15. Claudia Duranti · 1 shared paper, 2023 · strength 0.16
  16. Tiziano Lottini · 1 shared paper, 2023 · strength 0.16
  17. Elena Lastraioli · 1 shared paper, 2023 · strength 0.16
  18. Stefano Coppola · 1 shared paper, 2023 · strength 0.16
  19. Annarosa Arcangeli · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.